Дисфункция щитовидной железы и сердечно-сосудистые заболевания: состояние проблемы, пути решения

V.Z. Netyazhenko; A.V. Liakhotska

doi:10.22141/2224-0721.16.4.2020.208487

Published: May 1, 2020

DOI: https://doi.org/10.22141/2224-0721.16.4.2020.208487

Keywords:

Thyroid diseases are widespread and are the most common endocrine pathology, especially in regions with iodine deficiency in the environment. Thyroid dysfunction is diagnosed in 5–10 % of the population, more often in women and in the age group over 60 years. With increasing age, the occurrence of c

V.Z. Netyazhenko

Bogomolets National Medical University, Kyiv, Ukraine State Scientific Institution “Scientific and Practical Center of Preventive and Clinical Medicine” of the Agency of State Affairs, Kyiv, Ukraine

A.V. Liakhotska

Bogomolets National Medical University, Kyiv, Ukraine State Scientific Institution “Scientific and Practical Center of Preventive and Clinical Medicine” of the Agency of State Affairs, Kyiv, Ukraine

Abstract

Thyroid diseases are widespread and are the most common endocrine pathology, especially in regions with iodine deficiency in the environment. Thyroid dysfunction is diagnosed in 5–10 % of the population, more often in women and in the age group over 60 years. With increasing age, the occurrence of comorbid diseases in patients is increasing significantly. Among them, the first place belongs to the pathology of the cardiovascular system. One of the factors is endothelial dysfunction, which is one of the predictors of morphological changes in the vascular wall in many chronic diseases, in particular, atherosclerosis, arterial hypertension, thyroid diseases, and others.

How to Cite

Netyazhenko, V., and A. Liakhotska. “Thyroid Dysfunction and Cardiovascular Diseases: Problem and Ways to Solve It”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 16, no. 4, May 2020, pp. 333-6, doi:10.22141/2224-0721.16.4.2020.208487.

Issue

Vol. 16 No. 4 (2020)

Section

To practicing Endocrinologists

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.

References

Center for Medical Statistics. Indicators of public health and use of health care resources in Ukraine for 2017. 2017. (in Ukrainian). Available from: http://medstat.gov.ua/ukr/MMXVII.html.

Center for Medical Statistics Indicators of hospital morbidity in Ukraine for 2018. 2018. (In Ukrainian). Available from: http://medstat.gov.ua/ukr/MMXVII.html.

Rugge JB, Bougatsos C, Chou R. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(1):35-45. doi:10.7326/M14-1456.

Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374. doi:10.1001/jama.2010.1361.

Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J. 2015;4(3):149-163. doi:10.1159/000438750.

Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):55-59. doi:10.14797/mdcj-13-2-55.

Pankiv VI, Yuzvenko TYu, Pankiv IV. Type 2 diabetes mellitus and subclinical hypothyroidism: focusing on the role of cholecalciferol. Problemi endokrinnoi patologii. 2019;(2):46-51. doi:10.21856/j-PEP.2019.2.07.

Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39-55. doi:10.1038/nrcardio.2016.174.

Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181-186. doi:10.1530/eje.1.02333.

Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005;118(2):132-136. doi:10.1016/j.amjmed.2004.07.052.

Rodondi N, Bauer DC, Cappola AR, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol. 2008;52(14):1152-1159. doi:10.1016/j.jacc.2008.07.009.

Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J. 2018;39(7):503-507. doi:10.1093/eurheartj/ehx050.

Knuuti J, Wijns W, Saraste A, at al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology. European Heart Journal. 2020;41(3):407-477. doi:10.1093/eurheartj/ehz425.

Pashkovska NV. Pseudothyroid dysfunction in clinical practice: how to avoid diagnostic errors. Mìžnarodnij endokrinologìčnij žurnal. 2018;14(4):344-353. doi:10.22141/2224-0721.14.4.2018.140188. (in Ukrainian).